Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant | MicrobiomeTrials← Back to trialsNCT05722210
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-10-29Est. Completion: 2031-06-30
Enrollment target: 500 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
DOCK8 Deficiency
Background:
-DOCK8 deficiency is a genetic disorder that affects the immune system and can lead to severe recurrent inf…
Bethesda, United StatesEst. completion Oct 31, 2026
Transplant Associated Microangiopathy TAMTransplant Complication
The goal of this observational study is to learn about the incidence of Transplant Associated Thrombotich Microangiopath…
Birmingham, United StatesEst. completion Feb 2028
Phase 3
Recruiting
Ganglioneuroblastoma, NodularNeuroblastoma
This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care su…
Birmingham, United StatesEst. completion Dec 31, 2029